Thomas H. Lee Advisors, LLCInstitutional Owner
Sell $111.1M of disclosed value in The Dun & Bradstreet Corp $DNB.
Sell $111.1M of disclosed value in The Dun & Bradstreet Corp $DNB.
Buy $42.4M of disclosed value in Acrivon Therapeutics, Inc. Common Stock $ACRV.
Sell $41.0M of disclosed value in PlayAGS, Inc. $AGS.
Sell $11.5M of disclosed value in DZS Inc. $DZSIQ.
Buy $10.0M of disclosed value in ClearBridge MLP and Midstream Fund Inc. Common Sto $CEM.
Sell $5.1M of disclosed value in Royalty Pharma plc $RPRX.
Buy $5.0M of disclosed value in Acrivon Therapeutics, Inc. Common Stock $ACRV.
Buy $3.2B of disclosed value in Pacer MSCI World Industry Advantage ETF $GLBL.
Sell $2.3M of disclosed value in Prestige Consumer Healthcare Inc. $PBH.
Sell $2.0M of disclosed value in Rambus Inc $RMBS.
Sell $73M of disclosed value in Shoals Technologies Group, Inc. - Class A $SHLS.
Sell $1.2M of disclosed value in Synaptics Incorporated $SYNA.
Sell $883.2K of disclosed value in CNA Financial Corporation $CNA.
Sell $67.4M of disclosed value in FABRINET $FN.
Sell $750.7K of disclosed value in SolarEdge Technologies Inc $SEDG.
Sell $660.9K of disclosed value in Wallgreens Boots Alliance Inc $WBA.
Sell $438.6K of disclosed value in Mesa Laboratories, Inc. $MLAB.
Sell $2.4M of disclosed value in Addus HomeCare Corporation $ADUS.
Sell $2.7M of disclosed value in InfuSystem Holdings, Inc. $INFU.
Buy $327.4K of disclosed value in Treace Medical Concepts, Inc. $TMCI.